Nanjing Vazyme Biotech Co (SHSE:688105) Tariff Resilience Score: 0/10 (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688105 Nanjing Vazyme Biotech Co Ltd SHSE:688105
74 GF Score
Price ¥20.17
GF Value ¥17.70
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Nanjing Vazyme Biotech Co Tariff Resilience Score?

Nanjing Vazyme Biotech Co has the Tariff Resilience Score of 0, which implies that the company might have .

Nanjing Vazyme Biotech Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Nanjing Vazyme Biotech Co might have .

Nanjing Vazyme Biotech Co  (SHSE:688105) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Nanjing Vazyme Biotech Co Tariff Resilience Score Related Terms

SHSE:688105
74GF Score
Nanjing Vazyme Biotech Co Ltd SHSE:688105
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nanjing Vazyme Biotech Co (SHSE:688105) Overvalued in 2026?

Based on GuruFocus' analysis, Nanjing Vazyme Biotech Co stock appears to be overvalued. The current stock price of ¥20.17 is trading 14% above its estimated GF Value™ of ¥17.70. GuruFocus considers Nanjing Vazyme Biotech Co to be Modestly Overvalued.

Key valuation signals for SHSE:688105:

  • Tariff Resilience Score: 0
  • GF Value™: ¥17.70 vs. price of ¥20.17 (14% above fair value)
  • GF Score™: 74/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688105 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanjing Vazyme Biotech Co Business Description

Address Kechuang Road, Floor 1-6, East Section, Building C1-2, Hongfeng Science and Technology Park, Jiangsu, Economic and Technological Development Zone, Nanjing, CHN, 210000
Nanjing Vazyme Biotech Co Ltd is a biotechnology company. It is committed to research and development both in technology and products focusing on functional proteins, such as enzymes, antigens, antibodies, and polymer organic materials.
74GF Score

Get the complete analysis for SHSE:688105

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.17
Price
¥17.70
GF Value